Boston Scientific Corp. (NYSE:BSX) agreed to acquire Sadra Medical Inc. in a deal worth $450 million.
The acquisition of Los Gatos, Calif.-based Sadra marks the medical device giant’s entry into the aortic valve replacement market. Sadra is developing a device, the Lotus valve system, that’s designed to replace the valve that can be deployed via catheter; Boston Scientific became a strategic investor in the company in 2005 and owns 14 percent of Sadra, according to a press release.